| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740886 | Journal of Microbiology, Immunology and Infection | 2018 | 7 Pages |
Abstract
Cefoperazone-sulbactam at a 1:1 ratio has greater in vitro activity against most multidrug resistant organisms than cefoperazone-sulbactam at a 2:1 ratio. Such combinations were not influenced by the inoculum size of ESBL-producing E. coli and K. pneumoniae and could be a therapeutic option for treating severe infections.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ping-Chin Chang, Chi-Chung Chen, Ying Chen Lu, Chih-Cheng Lai, Hui-Ling Huang, Yin-Ching Chuang, Hung-Jen Tang,